Nanostructured Lipid Carriers As A Drug Delivery System

Authors

  • Ayush Nandkishore Mittal
  • Awate Shyam Suryakant
  • Sanjay R Arote
  • Varun Satish Pawar

DOI:

https://doi.org/10.63682/jns.v14i7.6456

Keywords:

Drug, Nanostructured Lipid Carriers (Nlc), Thermodurmal, Nanotechnology, Nateglinide

Abstract

Nanostructured Lipid Carriers (Nlcs) Are Drug Delivery System Comprising A Mixture Of Solid And Liquid Lipids As A Core Matrix. Furthermore, Nlcs Are Second-Generation Lipid Nanoparticles That Have An Unstructured Matrix With High Drug Loading Capacity, Which Are Suitable For Drug Delivery System. Due To These Unique Characteristics, Several Studies Have Investigated Nlcs As Alternate Carriers For The Dermal Delivery Of Pharmaceuticals, Particularly Natural Active Ingredients. Among The Associated Benefits Discovered Include Biocompatible Ingredients, Drug Release Modification, And Adhesion To The Skin, Film-Forming Ability With Hydration Of The Superficial Skin Layers, As Well As Increased Penetration And Permeation Into Deeper Skin Layers. Nlc It Can Be Easily Used As A Carrier For Drugs Via Different Routes Of Administration Such As Oral, Parenteral, Ocular, And Nasal. Nanostructured Lipid Carriers (Nlcs) Have Been Reported To Be An Alternative System And Are Considered Superior To Many Other Traditional Lipid-Based Nanocarriers Such As Emulsions, Nanoemulsion, Liposome, Microparticle, And Solid Lipid Nanoparticle (Slns). It Imparts Many Advantages Over Sln’s Such As Increased Solubility And Stability, Improved Permeability And Bioavailability, Enhanced Drug Loading Capacity, Drug Release Modulation Flexibility, Reduced Adverse Effects, Prolonged Half-Life, And Tissue-Targeted Delivery. This Review Highlights The Nlc With A Focus On The Structure ,Pharmaceutical And Therapeutic Applications Towards Targeted Drug Delivery Of Nlc In Delivery Systems

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Singh, S. K., Dadhania, P., Vuddanda, P. R., Jain, A., Velaga, S., & Singh, S. (2016). Intranasal Delivery Of Asenapine Loaded Nanostructured Lipid Carriers: Formulation, Characterization, Pharmacokinetic And Behavioural Assessment. Rsc Advances, 6(3), 2032-2045

Seyfoddin, A., & Al-Kassas, R. (2013). Development Of Solid Lipid Nanoparticles And Nanostructured Lipid Carriers For Improving Ocular Delivery Of Acyclovir. Drug Development And Industrial Pharmacy, 39(4), 508-519.

Poonia N, Kharb R, Lather V, Pandita D. Nanostructured Lipid Carriers: Versatile Oral Delivery Vehicle. Future Sci Oa 2016;2(3): Fso135. Doi: 10.4155/Fsoa-2016-0030

Neeraj, K. Garg., Nikunj, Tandel, Sanjay, Kumar Bhadada, And Rajeev, K. Tyagi., Nanostructured Lipid Carrier–Mediated Transdermal Delivery Of Aceclofenac Hydrogel Present An Effective Therapeutic Approach For Inflammatory Diseases.” Frontiers In Pharmacology. 12, 2012.

Khaled M Hosny Et Al., Development, Optimization, And Evaluation Of A Nanostructured Lipid Carrier Of Sesame Oil Loaded With Miconazole For The Treatment Of Oral Candidiasis Drug Deliv.29(1), 2022:254-262.

N, A. Shaikh., And R, R. Lala., “Formulation Development Of Dolutegravir Sodium Loaded Nano Lipid Carriers For Improved Solubility And Permeability.” Ijpsr. 12(7): 3654- 3665, 2021.

Nashwa Hassan., Shereen El-Adawy., Amal Ammar. And Ahmed, M. Samy., “Formulation And Evaluation Of Olmesartan Medoxomil As Solid Lipid Nanoparticles And Nano Structural Lipid Carriers.” Ijpbstm., 9 (2), Pp. 619-633, 2019

Radharani, Panda. Ketousetuo Kuotsu, “Fabrication, Characterization, And In Vitro Evaluation Of Pegylated Glyceride Labrasol® Nanostructured Lipid Carrier Composites Of Methotrexate: The Pathway To Effective Cancer Therapy.” Asian J Pharm Clin Res., 12(6), Pp.229-237, 2019.

Juntao Yin, Et Al., Selenium-Coated Nanostructured Lipid Carriers Used For Oral Delivery Of Berberine To Accomplish A Synergic Hypoglycemic Effect, Int J Nanomedicine. 12, 2017; 8671–8680.

Wei Huang, Huating Dou, Houjiu Wu, Zhigao Sun, Hua Wang And Linhua Huang. Preparation And Characterization Of Nobiletin-Loaded Nanostructured Lipid Carriers, Journal Of Nanomaterials, 2017 (2017), 1-10.

Keshri, L., & Pathak, K. (2013). Development Of Thermodynamically Stable Nanostructured Lipid Carrier System Using Central Composite Design For Zero Order Permeation Of Econazole Nitrate Through Epidermis. Pharmaceutical Development And Technology, 18(3), 634-644.

Zheng, K., Zou, A., Yang, X., Liu, F., Xia, Q., Ye, R., & Mu, B. (2013). The Effect Of Polymer–Surfactant Emulsifying Agent On The Formation And Stability Of Α-Lipoic Acid Loaded Nanostructured Lipid Carriers (Nlc). Food Hydrocolloids, 32(1), 72-78.

Gajanand Sharma, Kanika Thakur, Kaisar Raza, Bhupinder Singh, Om Parkash Katare. Nanostructured Lipid Carriers: A New Paradigm In Topical Delivery For Dermal And Transdermal Applications, Critical Reviews In Therapeutic Drug Carrier Systems. 34(4) (2017) 355-386.

Sun, M., Nie, S., Pan, X., Zhang, R., Fan, Z., & Wang, S. (2014). Quercetin-Nanostructured Lipid Carriers: Characteristics And Anti-Breast Cancer Activities In Vitro. Colloids And Surfaces B: Biointerfaces, 113, 15-24.

Marzia, Cirria., Lavinia, Maestrini., Francesca, Maestrelli., Natascia, Mennini., Paola, Mura., Carla, Ghelardinic., And Lorenzo, Di Cesare Mannelli., “Design, Characterization And In Vivo Evaluation Of Nanostructured Lipid Carriers (Nlc) As A New Drug Delivery System For Hydrochlorothiazide Oral Administration In Pediatric Therapy.” Drug Delivery.,25(1), Pp.1910- 1921, 2018

Jyotsana, R. Madan., K Swetha. D. Kamal., A. Rajendra., “Formulation, Optimization, And In Vitro Evaluation Of Nanostructured Lipid Carriers For Topical Delivery Of Apremilast.” Dermatologic Therapy. 33(3), E13370, Pp, 1-13, 2020

Downloads

Published

2025-05-24

How to Cite

1.
Mittal AN, Suryakant AS, Arote SR, Pawar VS. Nanostructured Lipid Carriers As A Drug Delivery System. J Neonatal Surg [Internet]. 2025May24 [cited 2025Sep.24];14(7):904-11. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/6456